| Rodney Teasley, | |
|
34509 9th Ave S Ste 202, Federal Way, WA 98003-8708 | |
| (253) 942-2270 | |
| (360) 377-1558 |
| Full Name | Rodney Teasley |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 10 Years |
| Location | 34509 9th Ave S Ste 202, Federal Way, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508285891 | NPI | - | NPPES |
| 2073239 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD60948061 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Community Hospital | Federal way, WA | Hospital |
| St Clare Hospital | Lakewood, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Medical Group | 0547173866 | 1115 |
News Archive
Kendle, a leading, global full-service clinical research organization, today announced it now offers Brain Network Activation imaging providing a non-invasive platform for mapping, monitoring and understanding brain electro-physiological network activity in response to cognitive or physiological stimuli. The BNA imaging technology was developed by ElMindA, a medical technology development company based in Herzliya, Israel.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Increasing the body's production of growth hormone may be an effective treatment for HIV lipodystrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection.
A study published today in EMBO Molecular Medicine reveals that the loss of function of the gene RARRES3 in breast cancer cells promotes metastasis to the lung.
On June 28, 2012 the Supreme Court ruled in favor of the Affordable Care Act by a 5-4 vote. This decision will ultimately impact all Americans, but targets the 16.3% of the population that was uninsured last year. That equates to 49.9 million Americans who could be seeking medical care.
› Verified 8 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
Kendle, a leading, global full-service clinical research organization, today announced it now offers Brain Network Activation imaging providing a non-invasive platform for mapping, monitoring and understanding brain electro-physiological network activity in response to cognitive or physiological stimuli. The BNA imaging technology was developed by ElMindA, a medical technology development company based in Herzliya, Israel.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Increasing the body's production of growth hormone may be an effective treatment for HIV lipodystrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection.
A study published today in EMBO Molecular Medicine reveals that the loss of function of the gene RARRES3 in breast cancer cells promotes metastasis to the lung.
On June 28, 2012 the Supreme Court ruled in favor of the Affordable Care Act by a 5-4 vote. This decision will ultimately impact all Americans, but targets the 16.3% of the population that was uninsured last year. That equates to 49.9 million Americans who could be seeking medical care.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rodney Teasley, 34509 9th Ave S Ste 202, Federal Way, WA 98003-8708 Ph: (253) 942-2270 | Rodney Teasley, 34509 9th Ave S Ste 202, Federal Way, WA 98003-8708 Ph: (253) 942-2270 |
News Archive
Kendle, a leading, global full-service clinical research organization, today announced it now offers Brain Network Activation imaging providing a non-invasive platform for mapping, monitoring and understanding brain electro-physiological network activity in response to cognitive or physiological stimuli. The BNA imaging technology was developed by ElMindA, a medical technology development company based in Herzliya, Israel.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Increasing the body's production of growth hormone may be an effective treatment for HIV lipodystrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection.
A study published today in EMBO Molecular Medicine reveals that the loss of function of the gene RARRES3 in breast cancer cells promotes metastasis to the lung.
On June 28, 2012 the Supreme Court ruled in favor of the Affordable Care Act by a 5-4 vote. This decision will ultimately impact all Americans, but targets the 16.3% of the population that was uninsured last year. That equates to 49.9 million Americans who could be seeking medical care.
› Verified 8 days ago
Daniel W Kozie, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 34612 6th Ave S, Federal Way, WA 98003 Phone: 253-661-2594 Fax: 253-661-2694 | |
Ryan E Stern, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S, Suite 110, Federal Way, WA 98003 Phone: 253-661-2594 | |
David Michael Johnson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S Ste 200, Federal Way, WA 98003 Phone: 253-661-2520 Fax: 253-661-2694 | |
Dr. Kirby J Lautman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S, Suite 200, Federal Way, WA 98003 Phone: 253-661-2594 Fax: 253-661-2694 | |
Mark B Emery, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S, Federal Way, WA 98003 Phone: 253-661-2594 Fax: 253-661-2694 | |
Mark D Hegewald, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S, Suite 200, Federal Way, WA 98003 Phone: 253-661-2594 Fax: 253-661-2694 |